Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Pieri

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Digestive Diseases and Sciences|May 3, 2025
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune HepatitisAndrea Pasta, Giulia Pieri, Maria Corina Plaz Torres, et al.
Cancers|January 21, 2023
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation AnalysisRodolfo Sacco, Daryl Ramai, Raffaella Tortora, et al.
Gastroenterology|August 28, 2014
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up studyWillem J Lammers, Henk R van Buuren, Gideon M Hirschfield, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2025
Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian StudyCristina Della Corte, Daphne D'Amato, Adele Rocchetti, et al.
Liver Cancer|April 22, 2026
Comparative Efficacy of Initial Treatment Strategies in Patients with Transarterial Chemoembolisation-Unsuitable Hepatocellular CarcinomaEdoardo G Giannini, Andrea Pasta, Giulia Pieri, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Digestive Diseases and Sciences|May 3, 2025
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune HepatitisAndrea Pasta, Giulia Pieri, Maria Corina Plaz Torres, et al.
Cancers|January 21, 2023
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation AnalysisRodolfo Sacco, Daryl Ramai, Raffaella Tortora, et al.
Gastroenterology|August 28, 2014
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up studyWillem J Lammers, Henk R van Buuren, Gideon M Hirschfield, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2025
Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian StudyCristina Della Corte, Daphne D'Amato, Adele Rocchetti, et al.
Liver Cancer|April 22, 2026
Comparative Efficacy of Initial Treatment Strategies in Patients with Transarterial Chemoembolisation-Unsuitable Hepatocellular CarcinomaEdoardo G Giannini, Andrea Pasta, Giulia Pieri, et al.
Pageof 5